How Oura Can Support Clinicians Caring for Patients Who Use GLP-1 Medications (opens in new tab)

GLP-1 medications are reshaping weight loss— but the benefits only last as long as patients are adherent. With real-world persistence falling to just 32% at one year, and evidence showing rapid reversal of gains after stopping, adherence is the defining clinical challenge of this therapeutic moment. Oura’s GLP-1 Insights feature was built to meet that […] The post appeared first on .